RENAL EXCRETION OF PERFLUOROOCTANOIC ACID IN MALE-RATS - INHIBITORY EFFECT OF TESTOSTERONE

被引:0
作者
VANDENHEUVEL, JP
DAVIS, JW
SOMMERS, R
PETERSON, RE
机构
[1] UNIV WISCONSIN, SCH PHARM, 425 N CHARTER ST, MADISON, WI 53706 USA
[2] UNIV WISCONSIN, CTR ENVIRONM TOXICOL, MADISON, WI 53706 USA
来源
JOURNAL OF BIOCHEMICAL TOXICOLOGY | 1992年 / 7卷 / 01期
关键词
PERFLUOROOCTANOIC ACID; RAT; EXCRETION; TESTOSTERONE; ESTRADIOL;
D O I
暂无
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
There is a marked sex difference in the whole-body elimination of perfluorooctanoic acid (PFOA) in rats, with females excreting the perfluorinated acid much more rapidly (half life [t1/2] < 1 day) than males (t1/2 = 15 days). Our objective was to determine if androgens or estrogens are involved in causing this sex difference in PFOA elimination. Castration of males greatly increased the elimination of [1-C-14]PFOA (9.4-mu-mol/kg, i.p.) in urine, demonstrating that a factor produced by the testis was responsible for the slow elimination of PFOA in male rats. Castration plus 17-beta-estradiol had no further effect on PFOA elimination whereas castration plus testosterone replacement at the physiologic level reduced PFOA elimination to the same level as rats with intact testes. Thus, in male rats, testosterone exerts an inhibitory effect on renal excretion of PFOA. In female rats, neither ovariectomy nor ovariectomy plus testosterone affected the PFOA urinary elimination, demonstrating that the inhibitory effect of testosterone on PFOA renal excretion is a male-specific response. Probenecid decreased the high rate of PFOA renal excretion in castrated males but had no effect on male rats with intact testes. We conclude that testosterone is a key determinant of the sex difference in PFOA elimination in rats.
引用
收藏
页码:31 / 36
页数:6
相关论文
共 21 条
  • [1] BOOKSTAFF RC, 1990, TOXICOL APPL PHARM
  • [2] CHARACTERISTICS OF CHEMICAL-BINDING TO ALPHA-2U-GLOBULIN INVITRO - EVALUATING STRUCTURE-ACTIVITY-RELATIONSHIPS
    BORGHOFF, SJ
    MILLER, AB
    BOWEN, JP
    SWENBERG, JA
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1991, 107 (02) : 228 - 238
  • [3] ANIMAL TOXICITY STUDIES WITH AMMONIUM PERFLUOROOCTANOATE
    GRIFFITH, FD
    LONG, JE
    [J]. AMERICAN INDUSTRIAL HYGIENE ASSOCIATION JOURNAL, 1980, 41 (08): : 576 - 583
  • [4] SURFACE ACTIVE MATERIALS FROM PERFLUOROCARBOXYLIC AND PERFLUOROSULFONIC ACIDS
    GUENTHNER, RA
    VIETOR, ML
    [J]. INDUSTRIAL & ENGINEERING CHEMISTRY PRODUCT RESEARCH AND DEVELOPMENT, 1962, 1 (03): : 165 - &
  • [5] GUY WS, 1976, ACS SYM SER, P117
  • [6] HANHIJARVI H, 1982, P SOC EXP BIOL MED, V171, P50
  • [7] ELIMINATION AND TOXICITY OF PERFLUOROOCTANOIC ACID DURING SUBCHRONIC ADMINISTRATION IN THE WISTAR RAT
    HANHIJARVI, H
    YLINEN, M
    KOJO, A
    KOSMA, VM
    [J]. PHARMACOLOGY & TOXICOLOGY, 1987, 61 (01): : 66 - 68
  • [8] DISPOSITION OF PERFLUORODECANOIC ACID IN MALE AND FEMALE RATS
    HEUVEL, JPV
    KUSLIKIS, BI
    VANRAFELGHEM, MJ
    PETERSON, RE
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1991, 107 (03) : 450 - 459
  • [9] SEX DIFFERENCE IN TRANSPORT OF P-AMINOHIPPURATE BY RAT KIDNEY
    KLEINMAN, LI
    LOEWENSTEIN, MS
    GOLDSTEIN, L
    [J]. ENDOCRINOLOGY, 1966, 78 (02) : 403 - +
  • [10] KOJO A, 1986, ARCH TOXICOL, P465